Recommended Treatment for Vitamin D Deficiency
For vitamin D deficiency, the recommended treatment is ergocalciferol (vitamin D2) or cholecalciferol (vitamin D3) 50,000 IU weekly for 8 weeks, followed by maintenance therapy of 1,000-2,000 IU daily or 50,000 IU monthly. 1
Diagnosis and Treatment Thresholds
- Vitamin D deficiency is defined as serum 25-hydroxyvitamin D level <20 ng/mL (50 nmol/L)
- Vitamin D insufficiency is defined as serum 25-hydroxyvitamin D level of 20-30 ng/mL (50-75 nmol/L)
- Treatment goal: Achieve and maintain serum 25(OH)D levels >30 ng/mL (75 nmol/L) 1
Treatment Protocol
Initial Repletion Phase
- First-line therapy:
Maintenance Phase
After normalization of vitamin D levels:
Population-Specific Recommendations
| Population | Recommended Daily Dose |
|---|---|
| Adults up to age 70 | 600 IU/day |
| Adults over 70 years | 800 IU/day |
| Dark-skinned or veiled individuals | 800 IU/day |
| Institutionalized individuals | 800 IU/day |
Monitoring Recommendations
- Check serum calcium, phosphorus, and 25-hydroxyvitamin D levels:
- Monthly for the first 3 months
- Every 3 months thereafter 1
- Discontinue vitamin D therapy immediately if:
- Serum calcium exceeds 10.2 mg/dL
- Serum phosphorus exceeds 4.6 mg/dL 1
Special Considerations
Chronic Kidney Disease
- For GFR >30 mL/min/1.73m²: Follow general population recommendations (800-1,000 IU daily)
- For GFR <30 mL/min/1.73m²: Either supplementing or not supplementing at doses up to ~4,000 IU daily is reasonable based on clinical judgment 1
Safety and Toxicity
- Safe upper limit for most adults: 4,000 IU daily
- Ultra-high single loading doses (>300,000 IU) are not recommended due to risk of toxicity 1
- Vitamin D toxicity typically occurs at levels above 150 ng/mL 1
Important Precautions
- Evaluate all sources of vitamin D intake (fortified foods, supplements, prescription drugs) 4
- Readjust therapeutic dosage as soon as there is clinical improvement 4
- Monitor closely when using high therapeutic doses, particularly in vitamin D resistant rickets where the therapeutic window is narrow 4
- Mineral oil interferes with vitamin D absorption 4
- Thiazide diuretics may cause hypercalcemia in hypoparathyroid patients treated with ergocalciferol 4
Treatment Efficacy Considerations
- Cholecalciferol (vitamin D3) appears to be more potent than ergocalciferol (vitamin D2), with studies showing it to be approximately 3.2-fold more potent 5
- Calcifediol (25OHD3) results in a more rapid increase in serum 25OHD compared to oral cholecalciferol and may be considered as an alternative, especially in patients with malabsorption 5
Regular monitoring and appropriate dosing adjustments are essential to achieve optimal vitamin D levels while avoiding potential toxicity.